Bacteraemia Incidence After Micra Leadless Pacemaker Implantation

A retrospective cohort study from the University Hospitals of Leuven reports on bacteraemia incidence in 155 patients implanted with a Micra leadless pacemaker between July 2015 and July 2019. The data includes 15 patients who developed bacteraemia, with details on infection timing, bacterial species, and patient outcomes. The study was authored by Christophe Garweg and is available via Open Access.

Use Cases

• Analyze the incidence of bacteraemia based on the reported cohort of 155 patients.
• Study the timing of infection onset based on the median of 226 days post-implant.
• Investigate bacterial species distribution based on the reported Gram-positive species accounting for 73.3% of cases.
• Associate infection sources with patient outcomes based on the identified sources in 60% of bacteraemia cases.

Strengths

• Includes a defined cohort of 155 patients with a specific implant type and time range.
• Reports detailed outcomes for 15 bacteraemia cases, including bacterial species and infection sources.
• Provides median follow-up duration of 263 days for patient outcomes.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect geographic and institutional bias inherent to a single-center study.

Provenance

Source

Universitair Ziekenhuis Leuven

Collection Method

Retrospective cohort study

Time Range

July 2015 to July 2019

Geography

Leuven, Belgium